Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00672893
Other study ID # DB035-Multi-site
Secondary ID DB020-Single-sit
Status Completed
Phase N/A
First received May 1, 2008
Last updated June 15, 2009
Start date February 2006
Est. completion date December 2008

Study information

Verified date June 2009
Source Deep Breeze
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Vibration response imaging (VRI) technology, provides a radiation-free dynamic image of the lung, by visualizing vibration energy emitted during the respiration cycle (lung sounds). Airflow in the lungs during the respiration cycle creates vibrations that propagate through the lung tissue; these vibrations are affected by the structural properties of the lungs and may vary in space, time and frequency. Moreover, any structural alteration, such as a bronchial obstruction or space occupying infiltration, is reflected in a corresponding modification of the vibration response.

As obstructions that occur in airways alter airflow, the VRI may provide additional lung function information prior to treatment for airway obstruction and during follow-up. Moreover, the VRI may provide the physician immediate evaluation of the improvement of air flow distribution, quantitative and qualitative measurements. Furthermore, the VRI is a non-invasive, radiation free procedure which is simple and doesn't require the level of patient effort required for lung function test and other evaluation.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date December 2008
Est. primary completion date December 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Patient is able to read and understand the Informed Consent Form and he/she will sign the Informed Consent.

- Male or female in the age range of 18-85 years.

- Body Mass Index >20.

- Patient presented with airway obstruction and who are designated to undergo intervention

Exclusion Criteria:

- Chest wall deformity;

- Spine deformity (including severe scoliosis or kyphosis);

- Hirsutism;

- Potentially contagious skin lesion on the back;

- Skin lesion that would interfere with sensor placement;

- Patient is pregnant;

- Cardiac pacemaker or implantable defibrillator;

Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
Vibration Response Imaging
12 seconds of recording lung sounds

Locations

Country Name City State
France Hospital St. Marguerite Marseille
Germany Thoraxklinik at Heidelberg University Heidelberg
Japan St. Marianna Hospital Kawasaki Kanagawa
United States National Jewish Medical and Research Center Denver Colorado
United States Duke University Medical Center Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Deep Breeze

Countries where clinical trial is conducted

United States,  France,  Germany,  Japan, 

References & Publications (2)

Dellinger RP, Parrillo JE, Kushnir A, Rossi M, Kushnir I. Dynamic visualization of lung sounds with a vibration response device: a case series. Respiration. 2008;75(1):60-72. Epub 2007 Jun 4. — View Citation

Ernst A, Feller-Kopman D, Becker HD, Mehta AC. Central airway obstruction. Am J Respir Crit Care Med. 2004 Jun 15;169(12):1278-97. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The principal objective is to determine the ability of the VRI to assess changes in the lungs before and after pulmonary intervention in patients suffering from airway obstruction. Baseline and follow-up up to 3 months No
Secondary The secondary objective is to assess the contribution of the VRI in aiding in identification of the pulmonary obstruction as compared to the standard methods prior the intervention procedure. Baseline No
See also
  Status Clinical Trial Phase
Recruiting NCT02289586 - Interventional Bronchoscopy Under Noninvasive Ventilation N/A
Completed NCT02363959 - Hyperbaric Oxygen Therapy for Lung Transplantation Phase 2